PMID- 30168252 OWN - NLM STAT- MEDLINE DCOM- 20190130 LR - 20190130 IS - 1447-0594 (Electronic) IS - 1447-0594 (Linking) VI - 18 IP - 10 DP - 2018 Oct TI - Clinical features and outcomes in patients with elderly-onset anti-neutrophil cytoplasmic antibody-associated vasculitis. PG - 1453-1457 LID - 10.1111/ggi.13511 [doi] AB - AIM: Anti-neutrophil cytoplasmic antibody-associated vasculitis (AAV) is commonly seen in older patients. The present study intended to clarify whether elderly-onset AAV (at age >/=75 years) shows any specific clinical features and outcomes in Japanese patients. METHODS: This study was a retrospective cohort study. A total of 36 AAV patients who were initially treated at the Department of Rheumatology, Fukushima Medical University Hospital (Fukushima, Japan) between 2004 and 2016 were included. AAV patients were divided into an elderly group (>/=75 years) and a younger group (<75 years), and their clinical records were reviewed. RESULTS: Elderly AAV patients showed similar clinical features to younger AAV patients, except that they were more often women, weighed less, had an increased frequency of kidney involvement and had lower serum ferritin levels. Kaplan-Meier analyses showed significantly lower 1-year survival in elderly AAV (P =0.008) as well as AAV patients enrolled not receiving additional immunosuppressive treatment (P =0.023). The cause of death was disease progression itself or infection. CONCLUSIONS: The clinical features of AAV are similar between elderly and younger patients, except for increased kidney involvement and lower serum ferritin levels. Proper monitoring of the disease and adverse events, and providing conventional immunosuppressive therapy is suggested to avoid a poor outcome, especially in elderly AAV patients. Geriatr Gerontol Int 2018; 18: 1453-1457. CI - (c) 2018 Japan Geriatrics Society. FAU - Sato, Shuzo AU - Sato S AUID- ORCID: 0000-0002-8110-8261 AD - Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan. FAU - Yashiro, Makiko AU - Yashiro M AD - Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan. FAU - Matsuoka, Naoki AU - Matsuoka N AD - Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan. FAU - Asano, Tomoyuki AU - Asano T AD - Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan. FAU - Kobayashi, Hiroko AU - Kobayashi H AD - Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan. FAU - Watanabe, Hiroshi AU - Watanabe H AD - Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan. FAU - Migita, Kiyoshi AU - Migita K AD - Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan. LA - eng PT - Journal Article DEP - 20180830 PL - Japan TA - Geriatr Gerontol Int JT - Geriatrics & gerontology international JID - 101135738 RN - 0 (Immunosuppressive Agents) SB - IM MH - Age of Onset MH - Aged MH - Aged, 80 and over MH - Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis/*diagnosis/drug therapy/*mortality MH - *Cause of Death MH - Cohort Studies MH - Disease Progression MH - Female MH - Hospitals, University MH - Humans MH - Immunosuppressive Agents/*therapeutic use MH - Japan MH - Kaplan-Meier Estimate MH - Male MH - Prognosis MH - Retrospective Studies MH - Risk Assessment MH - Severity of Illness Index MH - Survival Rate OTO - NOTNLM OT - anti-neutrophil cytoplasmic antibody-associated vasculitis OT - clinical features OT - elderly onset OT - ferritin OT - outcome EDAT- 2018/09/01 06:00 MHDA- 2019/01/31 06:00 CRDT- 2018/09/01 06:00 PHST- 2017/12/13 00:00 [received] PHST- 2018/07/01 00:00 [revised] PHST- 2018/07/14 00:00 [accepted] PHST- 2018/09/01 06:00 [pubmed] PHST- 2019/01/31 06:00 [medline] PHST- 2018/09/01 06:00 [entrez] AID - 10.1111/ggi.13511 [doi] PST - ppublish SO - Geriatr Gerontol Int. 2018 Oct;18(10):1453-1457. doi: 10.1111/ggi.13511. Epub 2018 Aug 30.